Nicotinamide Adenine Dinucleotide Homeostasis in Cancer Patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1020210066

Enrollment

100

Registered

2022-01-28

Start date

2021-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing cancer treatment at Hirosaki university hospital from Dec. 2021. Subjects must meet the following criteria to be enrolled in this study. 1. Age >20 years. 2. Patients who have been fully informed about the participation in this study and have given written consent of their own free will with full understanding.

Exclusion criteria

Exclusion criteria: Patients who are judged by the principal investigator to be unsuitable as subjects.

Design outcomes

Primary

Measure	Time frame
Nicotinamide adenine dinucleotide levels at the time of the first visit to our department, at the time of admission for surgery, the day after surgery, and about one week after surgery	—

Secondary

Measure	Time frame
Correlation between nicotinamide adenine dinucleotide levels and clinical factors	—

Contacts

Public ContactKeinosuke Ishido

Hirosaki University Hospital

wakiya1979@hirosaki-u.ac.jp+81-172395079

Outcome results